SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-033576
Filing Date
2016-12-29
Accepted
2016-12-29 19:35:40
Documents
2
Period of Report
2016-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1700
2 ex24remeditexventures.txt EX-24 3641
  Complete submission text file 0001179110-16-033576.txt   7224
Mailing Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746
Business Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746 512-279-5100
LPATH, INC (Issuer) CIK: 0001251769 (see all company filings)

IRS No.: 161630142 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201
Business Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201 (214) 506-2662
Remeditex Ventures LLC (Reporting) CIK: 0001627363 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35706 | Film No.: 162076142